Page 433 - Read Online

Page 8 of 8 Panfoli et al. J Cancer Metastasis Treat 2020;6:35 I http://dx.doi.org/10.20517/2394-4722.2020.50

Proc Natl Acad Sci U S A 2017;114:10584-9.
45. Henderson MC, Azorsa DO. The genomic and proteomic content of cancer cell-derived exosomes. Front Oncol 2012;2:38.
46. Xiao H, Wong DT. Proteomic analysis of microvesicles in human saliva by gel electrophoresis with liquid chromatography-mass
spectrometry. Anal Chim Acta 2012;723:61-7.
47. Jayachandran A, Manda SV, Shrestha R, Bridle KR, Prithviraj P, et al. Exosome-based liquid biopsy in the management of hepatocellular
carcinoma. HR 2018;4:44.
48. Quandt D, Dieter Zucht H, Amann A, Wulf-Goldenberg A, Borrebaeck C, et al. Implementing liquid biopsies into clinical decision
making for cancer immunotherapy. Oncotarget 2017;8:48507-20.
49. Kim DK, Lee J, Simpson RJ, Lötvall J, Gho YS. EVpedia: a community web resource for prokaryotic and eukaryotic extracellular
vesicles research. Semin Cell Dev Biol 2015;40:4-7.
50. Skotland T, Ekroos K, Kauhanen D, Simolin H, Seierstad T, et al. Molecular lipid species in urinary exosomes as potential prostate cancer
biomarkers. Eur J Cancer 2017;70:122-32.
51. Melo SA, Luecke LB, Kahlert C, Fernandez AF, Gammon ST, et al. Glypican-1 identifies cancer exosomes and detects early pancreatic
cancer. Nature 2015;523:177-82.
52. Wang X, Luo G, Zhang K, Cao J, Huang C, et al. Hypoxic tumor-derived exosomal miR-301a mediates M2 macrophage polarization via
PTEN/PI3Kγ to promote pancreatic cancer metastasis. Cancer Res 2018;78:4586-98.
53. Bastos N, Ruivo CF, da Silva S, Melo SA. Exosomes in cancer: use them or target them? Semin Cell Dev Biol 2018;78:13-21.
54. Pullan JE, Confeld MI, Osborn JK, Kim J, Sarkar K, et al. Exosomes as drug carriers for cancer therapy. Mol Pharm 2019;16:1789-98.
55. Kanchanapally R, Deshmukh SK, Chavva SR, Tyagi N, Srivastava SK, et al. Drug-loaded exosomal preparations from different cell types
exhibit distinctive loading capability, yield, and antitumor efficacies: a comparative analysis. Int J Nanomedicine 2019;14:531-41.
56. Luan X, Sansanaphongpricha K, Myers I, Chen H, Yuan H, et al. Engineering exosomes as refined biological nanoplatforms for drug
delivery. Acta Pharmacol Sin 2017;38:754-63.
57. Sato YT, Umezaki K, Sawada S, Mukai SA, Sasaki Y, et al. Engineering hybrid exosomes by membrane fusion with liposomes. Sci Rep
2016;6:21933.
58. Vakhshiteh F, Atyabi F, Ostad SN. Mesenchymal stem cell exosomes: a two-edged sword in cancer therapy. Int J Nanomedicine
2019;14:2847-59.
59. Ueda N, Atsuta I, Ayukawa Y, Yamaza T, Furuhashi A, et al. Novel application method for mesenchymal stem cell therapy utilizing its
attractant-responsive accumulation property. Appl Sci 2019;9:4908.
60. Harjunpää H, Llort Asens M, Guenther C, Fagerholm SC. Cell adhesion molecules and their roles and regulation in the immune and
tumor microenvironment. Front Immunol 2019;10:1078.
61. Chen G, Huang AC, Zhang W, Zhang G, Wu M, et al. Exosomal PD-L1 contributes to immunosuppression and is associated with anti-
PD-1 response. Nature 2018;560:382-6.
62. Bellavia D, Raimondo S, Calabrese G, Forte S, Cristaldi M, et al. Interleukin 3- receptor targeted exosomes inhibit in vitro and in vivo
chronic myelogenous leukemia cell growth. Theranostics 2017;7:1333-45.
63. Kim MS, Haney MJ, Zhao Y, Mahajan V, Deygen I, et al. Development of exosome-encapsulated paclitaxel to overcome MDR in cancer
cells. Nanomedicine 2016;12:655-64.
64. Bovy N, Blomme B, Frères P, Dederen S, Nivelles O, et al. Endothelial exosomes contribute to the antitumor response during breast
cancer neoadjuvant chemotherapy via microRNA transfer. Oncotarget 2015;6:10253-66.
65. Sun Z, Shi K, Yang S, Liu J, Zhou Q, et al. Effect of exosomal miRNA on cancer biology and clinical applications. Mol Cancer
2018;17:147.
66. Soung YH, Ford S, Zhang V, Chung J. Exosomes in cancer diagnostics. Cancers (Basel) 2017;9:8.
67. Rauschenberger L, Staar D, Thom K, Scharf C, Venz S, et al. Exosomal particles secreted by prostate cancer cells are potent mRNA and
protein vehicles for the interference of tumor and tumor environment. Prostate 2016;76:409-24.
68. Van Deun J, Mestdagh P, Agostinis P, Akay Ö, Anand S, et al; EV-TRACK Consortium. EV-TRACK: transparent reporting and
centralizing knowledge in extracellular vesicle research. Nat Methods 2017;14:228-32.